{"id":"W3111651503","doi":"10.1016/j.jval.2020.08.567","title":"PCV76 NEWLY Introduced Drugs for Second-LINE Treatment of Stable Angina: Approvals and Reimbursement Decisions in the UK, Canada, Australia and Scotland","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Ranolazine; Reimbursement; Trimetazidine; Ivabradine; Medicine; Nicorandil; Angina; Formulary; Health care; Intensive care medicine; Pharmacology; Internal medicine; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002235061,0.0001498224,0.0005910835,0.001924438,0.0007694883,0.003355301,0.0007539371,0.001269514,0.003101032],"category_scores_gemma":[0.009595685,0.0002786022,0.0008088532,0.003445153,0.00120774,0.0006861679,0.0007793044,0.001970853,0.0002134337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02339795,"about_ca_system_score_gemma":0.01876145,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7367076,"about_ca_topic_score_gemma":0.8370143,"domain_scores_codex":[0.9961486,0.000560547,0.0003438884,0.0002599668,0.001659724,0.001027203],"domain_scores_gemma":[0.988366,0.002736962,0.002508962,0.0001208636,0.002947904,0.003319324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009842107,0.0003604631,0.5550057,0.001962669,0.0007773813,0.006707734,0.004407085,0.006403624,0.004725502,0.03996817,0.07569082,0.2941487],"study_design_scores_gemma":[0.0003195904,0.0003370739,0.9593295,0.0003656457,0.0001542514,0.001104608,0.00137263,0.00153096,0.0005812251,0.0003958822,0.03441549,0.00009311982],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9035056,0.03183931,0.0003149919,0.02775526,0.0003737843,0.00007979524,0.006192068,0.00003181903,0.02990731],"genre_scores_gemma":[0.9817535,0.007864921,0.0003123429,0.002484889,0.0002385769,0.00001397003,0.001379273,0.00002210685,0.005930498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2632924,"threshold_uncertainty_score":0.5296859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1860747266441193,"score_gpt":0.3384927844051854,"score_spread":0.1524180577610661,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}